Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study

ダウンロード数 : ? 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/53156

言語	英語
著者	木下芳一 Kato Mototsugu Department of Gastroenterology, National Hospital Organization Hakodate Hospital, Hakodate, Hokkaido, Japan Fujishiro Mitsuhiro Department of Endoscopy and Endoscopic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan Masuyama Hironori Masuyama Gastrointestinal Clinic, Ohtawara, Tochigi, Japan Nakata Ryo Japanese Red Cross Medical Center, Tokyo, Japan Abe Hisanori Arita GI Hospital, Oita, Oita, Japan Kumagai Shinji Nakajima Hospital, Sendai, Miyagi, Japan Fukushima Yasushi Tokyo-Eki Center-Building Clinic, Tokyo, Japan Okubo Yoshiumi Clinical Development Department, EA Pharma Co., Ltd, Tokyo, Japan Hojo Seiichiro Clinical Data Science Department, Eisai Co., Ltd, Tokyo, Japan Kusano Motoyasu Department of Gastroenterology, Gunma University Hospital, Maebashi, Gunma, Japan
主題	Endoscopy; GERD; Los Angeles Classification; Proton pump inhibitor; Reflux esophagitis
掲載誌名	JOURNAL OF GASTROENTEROLOGY
巻	53
号	7
開始ページ	834
終了ページ	844
ISSN	0944-1174
ISSN（Online）	1435-5922
発行日	2018-07
DOI	10.1007/s00535-017-1417-z
PubMed ID	29188387
出版者	SPRINGER JAPAN KK
資料タイプ	学術雑誌論文
部局	医学部
備考	This study was funded by Eisai, Co., Ltd., Tokyo, Japan and EA Pharma Co., Ltd., Tokyo, Japan. The writing and preparation of this paper were funded in part by EA Pharma. Writing support was provided by Eisai. Data analyses were undertaken by Eisai.